23andMe makes $400m telehealth play, gulping down Lemonaid
pharmaphorum
OCTOBER 25, 2021
Consumer DNA testing company 23andMe has signed a deal to acquire privately-held Lemonaid Health in a $400 million deal that marks a move into the online health sector. The transaction is expected to close before the end of the year.
Let's personalize your content